Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice.

Windahl SH, Börjesson AE, Farman HH, Engdahl C, Movérare-Skrtic S, Sjögren K, Lagerquist MK, Kindblom JM, Koskela A, Tuukkanen J, Divieti Pajevic P, Feng JQ, Dahlman-Wright K, Antonson P, Gustafsson JÅ, Ohlsson C.

Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2294-9. doi: 10.1073/pnas.1220811110. Epub 2013 Jan 23.

2.

Estrogen receptor α in osteocytes regulates trabecular bone formation in female mice.

Kondoh S, Inoue K, Igarashi K, Sugizaki H, Shirode-Fukuda Y, Inoue E, Yu T, Takeuchi JK, Kanno J, Bonewald LF, Imai Y.

Bone. 2014 Mar;60:68-77. doi: 10.1016/j.bone.2013.12.005. Epub 2013 Dec 10.

3.

Inactivation of estrogen receptor α in bone-forming cells induces bone loss in female mice.

Määttä JA, Büki KG, Gu G, Alanne MH, Vääräniemi J, Liljenbäck H, Poutanen M, Härkönen P, Väänänen K.

FASEB J. 2013 Feb;27(2):478-88. doi: 10.1096/fj.12-213587. Epub 2012 Oct 16.

4.

PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.

Rhee Y, Allen MR, Condon K, Lezcano V, Ronda AC, Galli C, Olivos N, Passeri G, O'Brien CA, Bivi N, Plotkin LI, Bellido T.

J Bone Miner Res. 2011 May;26(5):1035-46. doi: 10.1002/jbmr.304.

5.

Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.

Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y, Nishina H, Takeda S, Takayanagi H, Metzger D, Kanno J, Takaoka K, Martin TJ, Chambon P, Kato S.

Cell. 2007 Sep 7;130(5):811-23.

6.

The effect of estrogen on bone requires ERα in nonhematopoietic cells but is enhanced by ERα in hematopoietic cells.

Henning P, Ohlsson C, Engdahl C, Farman H, Windahl SH, Carlsten H, Lagerquist MK.

Am J Physiol Endocrinol Metab. 2014 Oct 1;307(7):E589-95. doi: 10.1152/ajpendo.00255.2014. Epub 2014 Aug 12.

7.

Osteocytes use estrogen receptor alpha to respond to strain but their ERalpha content is regulated by estrogen.

Zaman G, Jessop HL, Muzylak M, De Souza RL, Pitsillides AA, Price JS, Lanyon LL.

J Bone Miner Res. 2006 Aug;21(8):1297-306.

8.

Constitutive protein kinase A activity in osteocytes and late osteoblasts produces an anabolic effect on bone.

Kao RS, Abbott MJ, Louie A, O'Carroll D, Lu W, Nissenson R.

Bone. 2013 Aug;55(2):277-87. doi: 10.1016/j.bone.2013.04.001. Epub 2013 Apr 10.

9.

Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice.

Xiao Z, Dallas M, Qiu N, Nicolella D, Cao L, Johnson M, Bonewald L, Quarles LD.

FASEB J. 2011 Jul;25(7):2418-32. doi: 10.1096/fj.10-180299. Epub 2011 Mar 31.

10.

The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone.

Martin-Millan M, Almeida M, Ambrogini E, Han L, Zhao H, Weinstein RS, Jilka RL, O'Brien CA, Manolagas SC.

Mol Endocrinol. 2010 Feb;24(2):323-34. doi: 10.1210/me.2009-0354. Epub 2010 Jan 6.

11.

Estrogen receptor-α expression in neuronal cells affects bone mass.

Ohlsson C, Engdahl C, Börjesson AE, Windahl SH, Studer E, Westberg L, Eriksson E, Koskela A, Tuukkanen J, Krust A, Chambon P, Carlsten H, Lagerquist MK.

Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):983-8. doi: 10.1073/pnas.1111436109. Epub 2012 Jan 3.

12.

Roles of transactivating functions 1 and 2 of estrogen receptor-alpha in bone.

Börjesson AE, Windahl SH, Lagerquist MK, Engdahl C, Frenkel B, Movérare-Skrtic S, Sjögren K, Kindblom JM, Stubelius A, Islander U, Antal MC, Krust A, Chambon P, Ohlsson C.

Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6288-93. doi: 10.1073/pnas.1100454108. Epub 2011 Mar 28.

13.

[Estrogen actions on osteocytes].

Kondoh S, Imai Y.

Clin Calcium. 2012 May;22(5):721-6. doi: CliCa1205721726. Review. Japanese.

PMID:
22549197
14.

Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling.

Canalis E, Adams DJ, Boskey A, Parker K, Kranz L, Zanotti S.

J Biol Chem. 2013 Aug 30;288(35):25614-25. doi: 10.1074/jbc.M113.470492. Epub 2013 Jul 24.

15.

Interleukin-11 receptor signaling is required for normal bone remodeling.

Sims NA, Jenkins BJ, Nakamura A, Quinn JM, Li R, Gillespie MT, Ernst M, Robb L, Martin TJ.

J Bone Miner Res. 2005 Jul;20(7):1093-102. Epub 2005 Feb 14.

16.

Additional weight bearing during exercise and estrogen in the rat: the effect on bone mass, turnover, and structure.

Tromp AM, Bravenboer N, Tanck E, Oostlander A, Holzmann PJ, Kostense PJ, Roos JC, Burger EH, Huiskes R, Lips P.

Calcif Tissue Int. 2006 Dec;79(6):404-15. Epub 2006 Dec 8.

PMID:
17160577
17.

A novel ligand-independent function of the estrogen receptor is essential for osteocyte and osteoblast mechanotransduction.

Aguirre JI, Plotkin LI, Gortazar AR, Millan MM, O'Brien CA, Manolagas SC, Bellido T.

J Biol Chem. 2007 Aug 31;282(35):25501-8. Epub 2007 Jul 3.

18.

Estrogen responsiveness of bone formation in vitro and altered bone phenotype in aged estrogen receptor-alpha-deficient male and female mice.

Parikka V, Peng Z, Hentunen T, Risteli J, Elo T, Väänänen HK, Härkönen P.

Eur J Endocrinol. 2005 Feb;152(2):301-14.

19.

Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males.

Sims NA, Dupont S, Krust A, Clement-Lacroix P, Minet D, Resche-Rigon M, Gaillard-Kelly M, Baron R.

Bone. 2002 Jan;30(1):18-25.

PMID:
11792560
20.

Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength.

Melville KM, Kelly NH, Khan SA, Schimenti JC, Ross FP, Main RP, van der Meulen MC.

J Bone Miner Res. 2014 Feb;29(2):370-9. doi: 10.1002/jbmr.2082.

Items per page

Supplemental Content

Write to the Help Desk